July 29, 2022 / 03:15 PM IST
Reported Standalone quarterly numbers for Strides Pharma Science are:Net Sales at Rs 423.19 crore in June 2022 down 16.82% from Rs. 508.79 crore in June 2021.
Story continues below Advertisement
Quarterly Net Loss at Rs. 66.25 crore in June 2022 down 212.06% from Rs. 21.23 crore in June 2021.
EBITDA stands negative at Rs. 53.56 crore in June 2022 down 416.17% from Rs. 16.94 crore in June 2021.
Strides Pharma shares closed at 334.45 on July 28, 2022 (NSE) and has given -15.00% returns over the last 6 months and -54.78% over the last 12 months.
Strides Pharma Science | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'22 | Mar'22 | Jun'21 | Net Sales/Income from operations | 423.19 | 455.66 | 508.79 | Other Operating Income | -- | -- | -- | Total Income From Operations | 423.19 | 455.66 | 508.79 | EXPENDITURE | Consumption of Raw Materials | 293.18 | 243.39 | 243.42 | Purchase of Traded Goods | 5.97 | 19.09 | 14.58 | Increase/Decrease in Stocks | -14.54 | 3.40 | 15.98 | Power & Fuel | -- | -- | -- | Employees Cost | 67.46 | 53.41 | 79.44 | Depreciation | 24.30 | 24.41 | 26.64 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 132.16 | 118.54 | 147.19 | P/L Before Other Inc. , Int., Excpt. Items & Tax | -85.33 | -6.58 | -18.45 | Other Income | 7.47 | 84.83 | 8.75 | P/L Before Int., Excpt. Items & Tax | -77.86 | 78.25 | -9.70 | Interest | 26.02 | 21.55 | 18.09 | P/L Before Exceptional Items & Tax | -103.88 | 56.71 | -27.79 | Exceptional Items | -- | -- | -- | P/L Before Tax | -103.88 | 56.71 | -27.79 | Tax | -37.63 | -143.80 | -6.56 | P/L After Tax from Ordinary Activities | -66.25 | 200.50 | -21.23 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -66.25 | 200.50 | -21.23 | Equity Share Capital | 89.79 | 89.79 | 89.72 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -7.38 | 22.33 | -2.37 | Diluted EPS | -7.38 | 22.33 | -2.37 | EPS After Extra Ordinary | Basic EPS | -7.38 | 22.33 | -2.37 | Diluted EPS | -7.38 | 22.33 | -2.37 | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!